Prevention of Adenovirus Infection with Recombinant Interferon 2b Medication in Preschool Institutions

Abstract

This article presents the results of experimental (on cell cultures) and clinical (in children’s groups) studies of recombinant interferon alpha-2b medication (Grippferon). Our aim was to examine the virus-inhibitory activity of this medication (against adenovirus) and its preventive effect (on causative agents of ARVI), which allows us to use this medication as a preventive measure against adenovirus (as well as any other) infection in children’s groups.

Keywords

• гриппферон
• детские коллективы
• аденовирус
• индекс эффективности